|
|
||||
|
Meet This Issue's Contributors
The Scientist 2005, 19(23):6
|
||||
|
|
||||
|
Michael Karin was born in Tel Aviv and came to the United States in 1975. With his group in the pharmacology department at the University of California, San Diego, he has uncovered key mechanisms of NF-κB signaling. He writes about the importance of this inflammatory pathway in cancer development on page 24. "A link between inflammation and cancer may have been suspected for millennia," he writes. "Nevertheless, the connection has failed to catch on with most oncologists."
|
|
|||||||||
|
|||||||||
|